The 2nd annual Festival of Biologics San Diego combines three outstanding conferences, focusing on antibodies, immunotherapy and biosimilars all under one roof.
The Festival of Biologics San Diego will bring together three high level, commercial events: The Americas Antibody Congress, the World Immunotherapy Congress USA, and the World Biosimilar Congress USA.
Biologics are transforming the lives of patients across the globe, and are poised to become even more important in upcoming years. In 2013 it was estimated that biologics provided close to 22% of global pharmaceutical sales, with the expectation for it to rise to 32% in 2023 (The Economist, 2013). Biologic sales are dominated by the US, with a market share of 43%. With massive biologic players such as AbbVie, Amgen and Genentech based in the US, and with over 15,000 individuals working within the biologics sphere in San Diego, the Festival of Biologics San Diego will have great global and local reach.